FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry and concerns a solid dosage form that exhibits the antiaggregatory activity and contains, wt %: clopidogrel hydrosulfate - 15-45; microcrystalline cellulose - 7-20; talc-1-3; sodium croscarmellose - 1-4; low-molecular polyvinylpyrrolidone - 0.3-10; stearic acid and/or its salts - 0.5-1; lactose - the rest, and a coating that contains, wt %: titanium dioxide - 8-30; polyethylene glycol - 6-28; talc - 5-25; carmine - 0.3-2.5; yellow aluminium lake - 0.05-1; red aluminium lake - 0.01-0.5; quinoline yellow aluminium lake - 0.01-0.05; polyvinyl alcohol - the rest. There is also disclosed a method for preparing the presented solid dosage form.
EFFECT: preparation of the solid dosage form that exhibits the antiaggregatory activity.
7 cl, 2 tbl
